CD4 and neoplasm: We have established survival rate of A20HA brain-tumor-bearing mice and demonstrated possibility of adoptively transferred CD4+ T cells to the tumor-specific activation in vivo as well as development of the tumor-specific anergy in process of the brain tumor progression.